37 filings
Page 2 of 2
8-K
2qbjbw9
11 May 22
Spruce Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:06pm
8-K
wu9vbam9rmked84qy
8 Apr 22
Departure of Directors or Certain Officers
5:27pm
8-K
24ce2pda
14 Mar 22
Other Events
4:35pm
8-K
8usxuzj
14 Mar 22
Spruce Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Updates
4:09pm
8-K
j18y b6yzjlr553h7j
5 Jan 22
Spruce Biosciences Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer
5:04pm
8-K
yya5h
15 Nov 21
Spruce Biosciences Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
12:00am
8-K
pttcchwqr 413uza8s
15 Sep 21
Regulation FD Disclosure
9:01am
8-K
nv79xofy8tycew
25 Aug 21
Regulation FD Disclosure
11:02am
8-K
nuf d4ton69aomfi
10 Aug 21
Spruce Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
4:14pm
8-K
a65cpvv3ob9g0olxuf
29 Jun 21
Departure of Directors or Certain Officers
4:12pm
8-K
w37q5
24 May 21
Submission of Matters to a Vote of Security Holders
4:37pm
8-K
n848k7467r70
12 May 21
Spruce Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Updates
4:09pm
8-K
5bolcq3z3 66dy6p
22 Mar 21
Spruce Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Recent Corporate Updates
4:18pm
8-K
es0 vdvelqiqc0
25 Feb 21
Departure of Directors or Certain Officers
11:00am
8-K
0fj6i5s 9gae4zz4h0
6 Jan 21
Spruce Biosciences Provides Corporate Update and Outlines Milestones for 2021
9:01am
8-K
9x26lssdb
18 Nov 20
Spruce Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:07pm
8-K
h9gwlg hvn
14 Oct 20
Spruce Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise
4:21pm